Fortress Biotech, Inc. (NASDAQ:FBIOP – Get Free Report)’s stock price was up 6.4% on Thursday . The stock traded as high as $9.03 and last traded at $9.01. Approximately 19,595 shares changed hands during mid-day trading, an increase of 40% from the average daily volume of 14,020 shares. The stock had previously closed at $8.47.
Fortress Biotech Price Performance
The business has a fifty day moving average of $7.89 and a 200 day moving average of $7.21.
About Fortress Biotech
Fortress Biotech, Inc, a biopharmaceutical company, develops dermatology, pharmaceutical, and biotechnology products in the United States. The company markets dermatology products, such as Qbrexza a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane capsules for severe recalcitrant nodular acne; Amzeeq for severe acne vulgaris; Zilxi, a topical foam; Exelderm cream and solution for topical use; Targadox an oral doxycycline drug for adjunctive therapy for severe acne; Luxamend; sulconazole nitrate cream and solution for tinea cruris and tinea corporis; and doxycycline hyclate tablet.
Read More
- Five stocks we like better than Fortress Biotech
- What is a penny stock? A comprehensive guide
- Why Seagate Is Wall Street’s New Favorite AI Infrastructure Play
- 3 Grocery Stocks That Are Proving They Are Still Essential
- 3 AI Infrastructure Stocks With Upside After the Summer Rally
- Financial Services Stocks Investing
- Can Advantage2 Help Overcome D-Wave’s Share Price Plateau?
Receive News & Ratings for Fortress Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fortress Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
